[Cardiology]

Nadia Kilani1, Christelle Haddad1, Henri Lu1

  • 1Service de cardiologie, CHUV, Université de Lausanne, 1011 Lausanne.

Revue Medicale Suisse
|January 28, 2021
PubMed

Insights

New European Society of Cardiology guidelines highlight SGLT2 inhibitors for heart failure and stress MRI for coronary artery disease screening. Transcatheter aortic valve replacement may allow anti-platelet monotherapy, and certain blood pressure drugs don't increase COVID-19 risk.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Imaging

Background:

  • The European Society of Cardiology released updated guidelines in 2020.
  • Key areas include non-ST-segment elevation acute coronary syndromes, atrial fibrillation, and adult congenital heart disease.
  • Advances in interventional cardiology, heart failure treatment, and cardiac imaging were noted.

Purpose of the Study:

  • To summarize significant findings and guideline updates from 2020 in cardiology.
  • To highlight advancements in transcatheter aortic valve replacement (TAVI) and heart failure pharmacotherapy.
  • To review the role of cardiac imaging and the impact of specific medications on COVID-19 risk.

Main Methods:

  • Review of 2020 European Society of Cardiology guidelines.
  • Analysis of key clinical trials like POPular TAVI and EMPEROR-Reduced.
  • Evaluation of the utility of stress MRI and the safety of renin-angiotensin-aldosterone inhibitors concerning COVID-19.

Main Results:

  • POPular TAVI trial suggests potential for anti-platelet monotherapy post-transcutaneous aortic valve replacement.
  • EMPEROR-Reduced trial reinforces the efficacy of SGLT2 inhibitors in heart failure with reduced ejection fraction.
  • Stress MRI is established as a first-line, cost-effective screening tool for coronary artery disease.
  • Renin-angiotensin-aldosterone inhibitors were not associated with an increased risk of COVID-19 infection.

Conclusions:

  • 2020 cardiology guidelines offer significant updates for clinical practice.
  • New therapeutic strategies and diagnostic tools are improving patient outcomes.
  • Current evidence supports the safety of certain cardiovascular medications in the context of COVID-19.

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
516
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
124
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
157
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
151
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.7K
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
140